Editorial: Host-microbe immunometabolic chat: a new era of organismal communication

• by Marco Gargaro, Francesca Fallarino, Teresa Zelante

• May 29, 2026

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

• by

• March 4, 2026

• 2 min

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

• by Bing Han, Ming-Yue Bao, Qing-Qing Sun, Rui-Ning Wang, Xin Deng, Kun Xing, Feng-Lin Yu, Yan Zhang, Yue-Bo Li, Xiu-Qing Li, Na-Nan Chai, Gai-Xin Ma, Ya-Na Yang, Meng-Yuan Tian, Qian Zhang, Xing Li, Yuan Zhang

• January 6, 2025